Is pleased to announce: Friday-Saturday, May 13-14, 2016 Memorial Sloan Kettering Symposium on Lymphoma State of the art in biology, therapy, and patient care CONFERENCE LOCATION MEMORIAL SLOAN KETTERING CANCER CENTER ZUCKERMAN RESEARCH CENTER NEW YORK To register or for more information, please go to: www.mskcc.org/lymphoma2016
9
Embed
Memorial Sloan Kettering Symposium on Lymphoma · 2016-04-25 · Is pleased to announce: Friday-Saturday, May 13-14, 2016 Memorial Sloan Kettering Symposium on Lymphoma State of the
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Is pleased to announce:
Friday-Saturday, May 13-14, 2016
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
CONFERENCE LOCATION
MEMORIAL SLOAN KETTERING CANCER CENTERZUCKERMAN RESEARCH CENTER
NEW YORKTo register or for more information, please go to:
www.mskcc.org/lymphoma2016
www.mskcc.org/lymphoma2016
Memorial Sloan Kettering Symposium on Lymphoma
Friday-Saturday, May 13-14, 2016
State of the art in biology, therapy, and patient care
TARGET AUDIENCEMedical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in diagnosis, treatment, and biomedical research of lymphoma.
COURSE OVERVIEWThis symposium will feature updated information on lymphoma biology, diagnosis, immunology, and genetics, and ongoing efforts to translate the scientific discoveries into novel treatment strategies for a variety of lymphomas. Faculty will review the current standard of care and present their own perspectives on how they treat various types of lymphomas. Participants will have the opportunity to discuss diagnostic and management cases, and how to incorporate biologic and genetic biomarkers into clinical practice and clinical trials.
You won't want to miss this unprecedented symposium focused on the future of Lymphoma with many of
the world’s leading experts.
www.mskcc.org/lymphoma2016
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
Friday-Saturday, May 13-14, 2016
SYMPOSIUM CHAIR
Anas Younes MD Chief, Lymphoma Service
ORGANIZING COMMITTEE
Ahmet Dogan MD PhD
Craig Moskowitz MD
Hans Guido Wendel MD
Joachim Yahalom MD FACR
Andrew Zelenetz MD PhD
Memorial Sloan Kettering Symposium on LymphomaState of the art in biology, therapy, and patient care
$200 Nurses, PAs, and other Healthcare Professionals
$100 Residents and Fellows
Registration includes continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with any special dietary needs.
To register, please go to:
www.mskcc.org/lymphoma2016The registration fee is waived for all MSK staff. However, you must register for the course by visiting the Continuing Medical Education page on OneMSK
OFFICE OF CONTINUING MEDICAL EDUCATIONMemorial Sloan Kettering Cancer Center633ThirdAvenue,12thfloor,NewYork,[email protected]
COURSE DESIGN
This symposium includes hands-on review of cases which will be intermixed with short didactic lectures. One workstation per participant.
EVALUATION
A course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.
ACCREDITATION STATEMENT
MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
MSK designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 17.25 AMA PRA Category 1 Credits™.
OUTCOMES MEASUREMENT SURVEY
Six months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.
FACULTY DISCLOSURE
It is the policy of MSK to make every effort to insure balance, independence, objectivity,andscientificrigorinallcontinuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected todiscloseanysignificantfinancialinterest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.
ACCOMMODATIONS
If you are traveling to MSK from outof town, we recommend that youreserve hotel rooms as early aspossible. To make the planning a littleeasier, MSK has negotiated rates atselect hotels in Manhattan. For a list of these hotels, please go to:www.mskcc.org/accommodations.